Moreover, our data and literature evidence collectively encourage further investigation to ascertain a possible functional role of RNY4 in ALCL disease aggressiveness, as well as in other lymphoproliferative diseases or different malignancies. Here, RNY4 is linked to anaplastic large cell lymphoma.